Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Geovax Labs (NQ: GOVX ) 1.610 -0.020 (-1.23%) Streaming Delayed Price Updated: 3:59 PM EDT, May 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Geovax Labs < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market May 17, 2024 ATLANTA, GA - (NewMediaWire) - May 17, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases,... Via TheNewswire.com Topics Regulatory Compliance Exposures Legal Regulatory GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market May 17, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Regulatory Compliance Exposures Legal Regulatory GOVX Stock Earnings: Geovax Labs Beats EPS for Q1 2024 May 15, 2024 GOVX stock results show that Geovax Labs beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 Presented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine candidate Via TheNewswire.com GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax to Present Data on GEO-CM04S1, A Next Generation Covid-19 Vaccine, at the World Vaccine Congress March 28, 2024 Via NewMediaWire Exposures COVID-19 GeoVax Labs, Inc. (NASDAQ: GOVX) Featured in Coverage of the 36th Annual Roth Conference March 08, 2024 Via Investor Brand Network Exposures COVID-19 Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential' May 09, 2024 Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists. Via Benzinga GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 May 07, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 May 07, 2024 GeoVax to Host Conference Call at 4:30 PM ET Via TheNewswire.com 12 Health Care Stocks Moving In Friday's Pre-Market Session April 05, 2024 Via Benzinga GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System March 06, 2024 Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines Via NewMediaWire Geovax Labs: Q4 Earnings Insights February 29, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Via Benzinga Earnings Outlook For Geovax Labs February 28, 2024 Via Benzinga GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine April 04, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine April 04, 2024 Presentation Made During the 24th Annual World Vaccine Congress Via TheNewswire.com Exposures COVID-19 GeoVax to Present at the 36th Annual Roth Conference March 12, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax Reports 2023 Year-End Financial Results and Provides Business Update February 29, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying February 23, 2024 The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 February 22, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 February 22, 2024 GeoVax to Host Conference Call at 4:30 PM ET Via TheNewswire.com GeoVax to Present at the 2024 BIO CEO & Investor Conference February 19, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax to Present at the 2024 BIO CEO & Investor Conference February 19, 2024 ATLANTA, GA - (NewMediaWire) - February 19, 2024 - Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today... Via TheNewswire.com GeoVax Announces Multiple Patent Issuances and Allowances February 13, 2024 Intellectual Property Assets Strengthened for Cancer Immunotherapy Program Via NewMediaWire Topics Intellectual Property Exposures Intellectual Property GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster February 06, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster February 06, 2024 Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants Via TheNewswire.com Exposures COVID-19 GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement January 29, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement January 29, 2024 ATLANTA, GA - (NewMediaWire) - January 29, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today... Via TheNewswire.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 24, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.